Rite Aid Corporation (NYSE:RAD) Files An 8-K Submission of Matters to a Vote of Security Holders

Rite Aid Corporation (NYSE:RAD) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders.

Story continues below

Rite Aid Corporation (“Rite Aid”) held its 2017 Annual Meeting of Stockholders on July 17, 2017. The following is a summary of the matters voted on at that meeting.

(a)

The stockholders elected Rite Aid’s nominees to the Board of Directors. The persons elected to Rite Aid’s Board of Directors and the number of shares cast for, the number against, the number abstaining and broker non-votes, with respect to each of these persons, were as follows:

Name

For

Against

Abstain

Broker Non-Votes

Joseph B. Anderson, Jr.

464,770,226

49,445,782

2,986,176

320,174,278

Bruce G. Bodaken

477,953,549

35,815,351

3,433,284

320,174,278

DavidR.Jessick

472,131,698

41,982,672

3,087,814

320,174,278

Kevin E. Lofton

481,799,040

32,052,691

3,350,453

320,174,278

Myrtle S. Potter

481,612,103

32,311,242

3,278,839

320,174,278

Michael N. Regan

466,751,575

47,432,815

3,017,794

320,174,278

Frank A. Savage

481,555,042

32,208,384

3,438,758

320,174,278

JohnT. Standley

455,990,232

43,129,384

18,082,568

320,174,278

Marcy Syms

468,516,136

45,785,726

2,900,322

320,174,278

(b)

The stockholders ratified the appointment of Deloitte& ToucheLLP as Rite Aid’s independent registered public accounting firm. The number of shares cast in favor of the ratification of Deloitte & Touche LLP, the number against, the number abstaining and broker non-votes were as follows:

For

Against

Abstain

Broker Non-Votes

783,512,050

45,808,434

8,055,978

(c)

The stockholders approved, on an advisory basis, the compensation of Rite Aid’s Named Executive Officers as set forth in Rite Aid’s proxy statement for the 2017 Annual Meeting of Stockholders. The number of shares cast in favor of the compensation of Rite Aid’s Named Executive Officers, the number against, the number abstaining and broker non-votes were as follows:

For

Against

Abstain

Broker Non-Votes

451,055,728

62,525,067

3,621,389

320,174,278

(d)

The stockholders recommended, on an advisory basis, a one year frequency of future advisory on the compensation of Rite Aid’s Named Executive Officers.The number of shares cast in favor of a one year frequency of future advisory votes, the number cast in favor of a two year frequency of future advisory votes, the number cast in favor of a three year frequency of future advisory votes, and the number abstaining were as follows:

One Year

Two Years

Three Years

Abstain

460,594,469

3,075,268

45,724,758

7,807,689

In consideration of the stockholder vote at the 2017 Annual Meeting of Stockholders on the frequency proposal, at a meeting of Rite Aid’s Board of Directors held immediately following the 2017 Annual Meeting of Stockholders, the Board decided that Rite Aid will hold an advisory “say-on-pay” vote every year in connection with its annual meeting of stockholders until the next stockholder vote on the frequency of “say-on-pay” votes, which will be no later than Rite Aid’s annual meeting of stockholders in 2023.


About Rite Aid Corporation (NYSE:RAD)

Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company’s Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.

An ad to help with our costs